GF Fund Management’s Disc Medicine IRON Stock Holding History

GF Fund Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.2K	Sell	809 -39	-5%	-$2.68K	﹤0.01%	375
2026 Q1	$54.2K	Buy	848 +106	+14%	+$7.36K	﹤0.01%	389
2025 Q4	$58.9K	Sell	742 -6	-0.8%	-$507	﹤0.01%	394
2025 Q3	$49.4K	Sell	748 -14	-2%	-$833	﹤0.01%	396
2025 Q2	$40.4K	Hold	762	–	–	﹤0.01%	438
2025 Q1	$37.8K	Buy	762 +137	+22%	+$7.62K	﹤0.01%	444
2024 Q4	$39.6K	Buy	+625	New	+$36.2K	﹤0.01%	414

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GF Fund Management's IRON Position: Q2 2026 in Review

GF Fund Management reduced its Disc Medicine (IRON) stake by 4.6% in Q2 2026, selling an estimated $2.68K and leaving 809 shares worth $59.2K. The position accounts for ﹤0.01% of the portfolio, ranked #375.

GF Fund Management first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

GF Fund Management held 809 shares of Disc Medicine worth $59.2K as of Q2 2026.
GF Fund Management sold 39 Disc Medicine shares in Q2 2026, an estimated $2.68K.
Disc Medicine made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #375 holding.
GF Fund Management first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.